Somavert

In the US, Somavert (pegvisomant systemic) is a member of the drug class growth hormone receptor blockers and is used to treat Acromegaly.

US matches:

• Somavert

UK matches:

• SOMAVERT 10mg, 15mg and 20mg powder and solvent for solution for injection
• SOMAVERT 10mg, 15mg & 20mg powder and solvent for solution for injection (SPC)

Ingredient matches for Somavert

Pegvisomant

Pegvisomant is reported as an ingredient of Somavert in the following countries:

• Argentina


• Austria


• Belgium


• Bulgaria


• Canada


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Mexico


• Netherlands


• Norway


• Portugal


• Serbia


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.